Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Update re. Belluscura IPO

1 Dec 2017 10:14

RNS Number : 1357Y
Tekcapital plc
01 December 2017
 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

1 December 2017

 

Tekcapital plc

("Tekcapital" or the "Company")

 

Update re. Belluscura IPO

 

Further to the announcement made on 16 November 2017, the Board of Tekcapital plc (AIM: TEK), a UK intellectual property (IP) investment group focused on creating marketplace value from university technology, today provides an update on the proposed IPO of Belluscura Limited ("Belluscura").

 

Due to current market conditions and certain other Enterprise Investment Scheme/Venture Capital Trust requirements having not been met in the expected timeframe, Belluscura is unable to proceed with the IPO and acquisition of licenses to manufacture and sell the STIC from Stryker Corporation. Belluscura is actively considering other alternatives.

 

 

For further information, please contact:

 

Tekcapital Plc

 

Clifford M. Gross, Ph.D.

info@tekcapital.com

 

Allenby Capital Limited (AIM Nominated

Adviser & Joint Broker)

 

+44 (0) 20 3328 5656

Jeremy Porter / Alex Brearley

 

 

 

Dowgate Capital Stockbrokers (Joint Broker)

+44 (0) 1293 517744

David Poutney / James Serjeant

 

 

 

Walbrook PR Ltd

+44 (0) 20 7933 8780

Paul Cornelius / Helen Cresswell / Sam Allen

tekcapital@walbrookpr.com

 

 

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital's objective is to create value from investing in new, university-developed intellectual properties and produce returns through capital appreciation. With its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital makes it easy to find and acquire the new IP needed to create a competitive advantage. Our IP services include invention discovery reports, search tools, analytics and IP professional recruitment to help universities and companies create value from new discoveries. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

LEI: 213800GOJTOV19FIFZ85

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
UPDEAEAFEFEXFFF
Date   Source Headline
27th May 20267:00 amRNSResults for Year Ended 31 December 2025
22nd May 20267:00 amRNSTekcapital takes stake in geothermal AI firm
21st May 20267:00 amRNSNew Orders
28th Apr 20267:00 amRNSStrategic Resale Alliance with Cardinal IP
18th Feb 20267:00 amRNSNotification of Major Holdings
10th Feb 20267:00 amRNSConditional Placing of £1.5 million
15th Jan 20267:00 amRNSCorporate Update
7th Jan 20267:00 amRNS-RPorfolio Company Update - Innovative Eyewear Inc
12th Dec 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear Inc
1st Dec 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
19th Nov 20257:00 amRNSPortfolio Company Update - Guident Corp
13th Nov 20257:00 amRNSInnovative Eyewear Q3 Unaudited Financial Results
13th Nov 20257:00 amRNSTrading Statement
10th Nov 20257:00 amRNS-RStrategic Alliance signed with Nexscient Inc
4th Nov 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
17th Oct 20254:15 pmRNSNotification of Major Holdings
13th Oct 20251:44 pmRNSPlacing of £0.37 Million
10th Oct 20257:00 amRNSNew Product Launch – Invention Validator
8th Oct 202510:53 amRNSReplacement - Unaudited Half-Yearly Report
7th Oct 20257:00 amRNS-RPortfolio Company Update Innovative Eyewear
6th Oct 20257:00 amRNSReplacement RNS: Half-year Report
30th Sep 20257:02 amRNSCommercial Strategy Update & New Products
30th Sep 20257:00 amRNSHalf-year Report
25th Sep 20257:00 amRNS-RPortfolio Company Update -Guident
24th Sep 20257:00 amRNSUnaudited Half Yearly Report
18th Sep 20257:00 amRNSPortfolio Company Update -Guident Proposed US IPO
10th Sep 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear
29th Aug 20257:00 amRNS-RPortfolio Company Update Guident Corp
19th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
15th Aug 20257:00 amRNS-RPortfolio Company Update Innovative Eyewear Q2
13th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
6th Aug 20257:00 amRNS-RPortfolio Company Update - Guident Corp
25th Jul 20257:00 amRNSTrading Statement
24th Jul 20257:00 amRNS-RPortfolio Company Update - Guident Corp
21st Jul 20257:00 amRNS-RPortfolio Company Update- Innovative Eyewear
27th Jun 202512:39 pmRNSResult of AGM
19th Jun 20251:06 pmRNSNotification of Major Holdings
19th Jun 202511:07 amRNSHolding(s) in Company - Replacement
19th Jun 20257:00 amRNS-RPortfolio Company Update - Guident Corp
10th Jun 20257:00 amRNSContract Win
2nd Jun 20257:02 amRNSNotice of AGM
2nd Jun 20257:00 amRNSFinal Results Year Ended 31 December Notice of AGM
2nd Jun 20257:00 amRNSFundraising of £1.25 Million
29th May 20257:00 amRNS-RPortfolio Company Update - Innovative Eyewear Inc
23rd May 20257:00 amRNSFinal Results Year Ended 31 December 2024
16th May 20257:00 amRNS-RPortfolio Company Update - Guident Corp
12th May 20257:00 amRNSPortfolio Company Update:Guident Corp Proposed IPO
6th May 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc.
28th Apr 20257:00 amRNSPortfolio Company Update - Innovative Eyewear Inc
24th Apr 20257:00 amRNSQ1 2025 Business Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.